Genmab revenue rises 25% in first half of 2026, guidance raised

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. AZN
7. ROIV
8. AAPL
9. HOOD
10. QQQ

Go back to Genmab revenue rises 25% in first half of 2026, guidance raised
(NASDAQ: GMAB) Delayed: 33.53 -0.07 (0.21%)
Previous Close $33.60    52 Week High $ 
Open $33.71    52 Week Low $ 
Day High $33.84    P/E N/A 
Day Low $33.36    EPS $ 
Volume 1,550,685